DBV Technologies S.A. DIO Ratio | DBVT

Annual DIO Ratio DBV Technologies S.A.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	-	332	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
332	332	332

Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
AbbVie ABBV	91.6	$ 293.87	0.19 %	$ 520 B	USA
Alnylam Pharmaceuticals ALNY	43.5	$ 151.6	-3.2 %	$ 19.9 B	USA
Axon Enterprise AXON	98.8	$ 302.6	-0.19 %	$ 23.6 B	USA
Theratechnologies THTX	373	-	-	$ 83.9 M	Canada
Bristol-Myers Squibb Company BMY	68.7	$ 62.8	1.06 %	$ 128 B	USA
Titan Pharmaceuticals TTNP	570	-	-3.76 %	$ 3.47 M	USA
CollPlant Biotechnologies Ltd. CLGN	221	$ 4.0	-6.76 %	$ 48.8 M	Israel
Ligand Pharmaceuticals Incorporated LGND	235	$ 317.26	0.99 %	$ 6.14 B	USA
Eli Lilly and Company LLY	352	$ 1 432.7	1.47 %	$ 1.29 T	USA
Crinetics Pharmaceuticals CRNX	343	$ 84.95	0.13 %	$ 7.99 B	USA
CorMedix CRMD	308	$ 5.37	-2.1 %	$ 387 K	USA
Adaptimmune Therapeutics plc ADAP	19.1 K	-	-15.15 %	$ 60.3 M	Britain
MannKind Corporation MNKD	430	$ 4.22	0.84 %	$ 1.29 B	USA
AVEO Pharmaceuticals AVEO	149	-	-	$ 521 M	USA
Merck & Co. MRK	142	$ 147.75	-0.68 %	$ 370 B	USA
Moderna MRNA	56.8	$ 250.79	-6.77 %	$ 97.6 B	USA
Dynavax Technologies Corporation DVAX	455	-	-	$ 2.02 B	USA
Novartis AG NVS	130	$ 163.39	-0.18 %	$ 317 B	Schweiz
Omeros Corporation OMER	484	$ 17.3	-1.48 %	$ 1.1 B	USA
Puma Biotechnology PBYI	44.7	$ 8.13	-3.22 %	$ 407 M	USA